A regular course of chemotherapy is recommended after bladder cancer surgery, followed by maintaining a happy mood and avoiding excessive stress. Secondly, when cancer patients receive tumor treatment, their immunity generally declines. When the body’s immunity is stronger than cancer cells Cancer will hide in the body, and when cancer cells are stronger than immunity, cancer cells will grow or spread quickly.

bladder cancer refers to bladder cancer Malignant tumor on the mucosa. It is the most common malignant tumor in the urinary system and one of the ten most common tumors in the whole body. In 2012, the incidence of bladder cancer in national tumor registration areas was 6.61 per 100,000, ranking 9th among malignant tumors. Bladder cancer can occur at any age, even in children. The incidence rate increases with age, with a high incidence age of 50 to 70 years. The incidence of bladder cancer in men is 3 to 4 times that in women. In the past, the bladder mucosal epithelium was called transitional cells. In 1998, WHO and the International Association of Urological Pathology jointly proposed to replace the term transitional cells with the term urothelial to distinguish it from the transitional epithelium in the nasal cavity and the ovary, so that the urothelial becomes urine. Proper noun for road system. The pathological types of bladder cancer in the histological classification of urinary tract system tumors in the 2004 WHO "Urinary System and Male Reproductive Organ Tumor Pathology and Genetics" include bladder urothelial carcinoma, bladder squamous cell carcinoma, bladder adenocarcinoma, other rare There are also bladder clear cell carcinoma, bladder small cell carcinoma, and bladder carcinoid. The most common of these is bladder urothelial carcinoma, which accounts for more than 90% of the total number of bladder cancer patients. The commonly referred to as bladder cancer refers to bladder urothelial carcinoma, formerly known as bladder transitional cell carcinoma.

Most scholars advocate the use of regular intravesical infusion chemotherapy after surgery. It is easy to operate and has good curative effect. It is the main means to prevent tumor recurrence and inhibit tumor development. The ideal bladder infusion chemotherapy should be that the drug can quickly reach the effective drug concentration in the bladder epithelium, and the systemic absorption is small, and the side effects are small. At present, bladder chemotherapy drugs are divided into two types: one is a biological agent, including BCG, interferon, etc.; the other is a chemical drug, such as mitomycin and doxorubicin. The former can prevent the recurrence and infiltration of tumors by inducing the body''s immune function; the latter can prolong the time of tumor recurrence. For adjuvant therapy, it is recommended to use a combination of traditional Chinese medicines, such as the anti-cancer component extracted from ginseng with patented technology-ginsenoside Rh2 can effectively alleviate the side effects of chemotherapy and increase the therapeutic effect. It can help patients reduce pain and successfully complete the treatment.